SDP has received research funding from AstraZeneca, Boehringer Ingelheim, Novartis Pharmaceuticals Co., and Merck Sharpe & Dohme, and is a consultant for or has received honoraria from AstraZeneca, Boehringer Ingelheim, Eli Lilly and Company, GlaxoSmithKline, Janssen Pharmaceuticals, Laboratoires Servier, Merck Sharp & Dohme, Novartis Pharmaceuticals Co., Novo Nordisk, Sanofi, and Takeda
Sumithran, P., et al
were further supported in part by funding from the Eric and Wendy Schmidt Center at the Broad Institute of MIT and Harvard
The safety and efficacy of citrus aurantium (bitter orange) extracts and p-synephrine: A systematic review and meta-analysis
Topiramate is contraindicated in pregnancy for migraine prophylaxis and requires highly effective contraception and signed risk acknowledgement for women who could become pregnant